About 50 MG Doxorubicin Injection IP
Explore the crackerjack world of oncology with 50 MG Doxorubicin Injection IP. This top-tier, prescription-only medication is expertly packaged in a sterile glass vial containing a spectacular, clear red, water-soluble solution. With a strength of 50 mg/vial, it's formulated for intravenous administration and boasts ideal compatibility with 0.9% Sodium Chloride and 5% Dextrose. Mark down its pH of 3.0-3.5 and specific gravity of approximately 1.01-1.03. Carefully handled by professionals in hospital settings, this exceptional product is essential for chemotherapy treatment, offering reliable results for breast, ovarian, and hematologic cancers. Secure this deal from India's leading exporters, suppliers, and traders.
Crackerjack Chemotherapy: Key Features and Uses
50 MG Doxorubicin Injection IP is a spectacular anti-cancer solution used commercially in hospitals for treating various cancers such as breast, lymphomas, leukemias, and ovarian cancer. Available as a sterile, single-dose vial, it is suitable for adult patients needing intravenous chemotherapy. This product's clear, red solution guarantees quality and consistent results. Markedly water-soluble and odorless, it enables smooth administration, making it suitable for use in oncology departments where precision, sterility, and patient safety are paramount.
Reliable Supply and Domestic Market Reach
We offer a consistent supply of 50 MG Doxorubicin Injection IP, prepared for swift shipment to hospitals and healthcare institutions across India's domestic market. This top-tier injection is shipped in compliance with cytotoxic handling standards, ensuring both safety and efficacy. For those wishing to evaluate the product before purchase, samples are available on request. Our extensive distribution network ensures that all deals are efficiently processed and the product reaches clients anywhere in the domestic region promptly.
FAQ's of 50 MG Doxorubicin Injection IP:
Q: How is 50 MG Doxorubicin Injection IP administered?
A: 50 MG Doxorubicin Injection IP is administered intravenously by a healthcare professional in a hospital setting. The solution is injected directly into the vein, ensuring controlled and effective delivery of the drug for chemotherapy.
Q: What cancers are treated with Doxorubicin Injection IP?
A: Doxorubicin Injection IP is indicated for a range of cancers, including breast cancer, lymphomas, leukemias, and ovarian cancer, making it a versatile option in anti-cancer chemotherapy protocols.
Q: Where should 50 MG Doxorubicin Injection IP be stored?
A: This injection must be stored in a dry place, in accordance with manufacturer instructions, to preserve its efficacy and stability throughout its 36-month shelf life.
Q: What precautions should be taken when handling Doxorubicin Injection?
A: As a cytotoxic agent, Doxorubicin Injection should only be handled by trained professionals in a hospital. Proper safety gear and protocols must be followed, and disposal should align with cytotoxic guidelines to avoid contamination or harm.
Q: When are samples of 50 MG Doxorubicin Injection IP available for clients?
A: Samples can be requested and are typically available before finalizing a bulk deal, enabling institutions to evaluate quality and compatibility within their oncological treatment standards.
Q: What are the main features that make this product suitable for chemotherapy?
A: The primary features include its sterile, single-dose vial format, water solubility, odorless and clear red appearance, compatibility with standard infusion solutions, and reliable supply, making it a trusted solution for chemotherapy applications.